510(k) Report

510(k) · Cleared

Cleared

Chad Therapeutic Evolution Electronic Oxygen Conserver with Motion

K113111510(k) SpecialCleared Dec 8, 201149-day reviewClass II21 CFR 868.5905

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Inovo, Inc. · NFB Conserver, Oxygen

Cleared on Dec 8, 2011 as substantially equivalent to K103392 (Inovo, Inc., 2010) and 1 other predicate after a 49-day review. Its family tree reaches back 3 generations to 2000. 1 later device descends from it.

Decided
Dec 8, 2011
Review
49 days
Class
Class II
Product code
NFB
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K003455 (2000). 7 ancestors in all, the oldest K961126 (1996). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2001: 1 other ancestor2000: 1 other ancestor1996: 1 other ancestor2022: 1 descendant clearedK003455 · Modification to Chad Therapeutics Oxymatic Model 401 · Chad Therapeutics, Inc. · 2000 · recalledK042142 · Chad Therapeutics Lotus, Models OM-700 and OM-700S · Chad Therapeutics, Inc. · 2004K103392 · Chad Therapeutic Evolution Electronic Oxygen Conserver · Inovo, Inc. · 20101995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors 1 generation forward: 1 descendant K103392 · Chad Therapeutic Evolution Electronic Oxygen Conserver · Inovo, Inc. · 2010K042142 · Chad Therapeutics Lotus, Models OM-700 and OM-700S · Chad Therapeutics, Inc. · 2004K003455 · Modification to Chad Therapeutics Oxymatic Model 401 · Chad Therapeutics, Inc. · 2000 · recalled0
  1. Root · 3 generations backK003455 Modification to Chad Therapeutics Oxymatic Model 401Chad Therapeutics, Inc. · 2000 · Recalled
  2. 2 generations backK042142 Chad Therapeutics Lotus, Models OM-700 and OM-700SChad Therapeutics, Inc. · 2004
  3. 1 generation backK103392 Chad Therapeutic Evolution Electronic Oxygen ConserverInovo, Inc. · 2010
  4. This deviceK113111 Chad Therapeutic Evolution Electronic Oxygen Conserver with MotionInovo, Inc. · 2011
  5. Descendant · cites it directly · 0 of its ownK220591 ProximaDynasthetics, LLC · 2022

Most influential descendants

Showing 1 of 1 · See all
  • K220591ProximaDynasthetics, LLC · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K003455Modification to Chad Therapeutics Oxymatic Model 401Chad Therapeutics, Inc.20001
−2K042142Chad Therapeutics Lotus, Models OM-700 and OM-700SChad Therapeutics, Inc.2004—
−1K103392Chad Therapeutic Evolution Electronic Oxygen ConserverInovo, Inc.2010—
0 (this device)K113111Chad Therapeutic Evolution Electronic Oxygen Conserver with MotionInovo, Inc.2011—
+1K220591ProximaDynasthetics, LLC2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200010
200110
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
FIG. 1 — Lineage of K113111, 2000–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NFB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NFB device

  1. #1 K250322 Respond OC Conserving Regulator (130-0800)score 10.6 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103392Chad Therapeutic Evolution Electronic Oxygen Conserver
Our reading of the summary gave K103302, FDA’s number for Stempro MSC SFM (Life Technologies Corporation). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “Chad Therapeutic Evolution Model OM-900”.
Inovo, Inc.2010—
*K033364Chad Therapeutics Sage
Summary page 2
…ceased, the software will then revert to the original rest setting(rest mode). The motion technology is taken from a previously cleared device Chad Sage Model TO-i100 - K033364. Intended Use: The Chad Therapeutics Evolution Model OM-900M is intended for prescription use only, to be used as part of a por…
Chad Therapeutics, Inc.2004—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K220591ProximaDynasthetics, LLC20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 3.8 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • Of its descendants, K220591 (Dynasthetics, LLC, 2022) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NFB devices

NFB Conserver, Oxygen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NFB

1in 2025

2007: 12009: 12010: 12011: 12013: 12016: 12020: 12022: 22025: 1
2007high 2 (2022) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NFB

Too few NFB 510(k)s in any year since 2007 to give a median.

Recalls per year · NFB

3in 2007

2007: 3
2007high 3 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NFB

8in 2025

2007: 32011: 12012: 32013: 52014: 22015: 42017: 92020: 32021: 22022: 12023: 42024: 12025: 8
2007high 9 (2017) · low 0 (2008)2025

MAUDE reports naming product code NFB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—33
20080—00
20091—00
20101—00
20111—01
20120—03
20131—05
20140—02
20150—04
20161—00
20170—09
20180—00
20190—00
20201—03
20210—02
20222—01
20230—04
20240—01
20251—08
20260—0—

What is it indicated for?

The Chad Therapeutics Evolution Model OM-900M is intended for prescription use only, to be used as part of a portable oxygen delivery system for patients that require supplemental oxygen up to 6 liters per minute, in their home and for ambulatory use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K113111: Chad Therapeutic Evolution Electronic Oxygen Conserver with Motion.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K113111

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026